• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The thorny issue of value alignment: how development-focused health technology assessment can help find win-win situations for patients and healthcare systems and commercial investors.

作者信息

Bouttell Janet, Briggs Andrew, Hawkins Neil

机构信息

Health Economics and Health Technology Assessment, University of Glasgow, 1 Lilybank Gardens, GlasgowG12 8RZ, UK.

Department of Health Services Research & Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, LondonWC1H 9SH, UK.

出版信息

Int J Technol Assess Health Care. 2021 Apr 20;37(1):e57. doi: 10.1017/S026646232100026X.

DOI:10.1017/S026646232100026X
PMID:33875040
Abstract
摘要

相似文献

1
The thorny issue of value alignment: how development-focused health technology assessment can help find win-win situations for patients and healthcare systems and commercial investors.价值协调这一棘手问题：以发展为重点的卫生技术评估如何有助于为患者、医疗系统和商业投资者找到双赢局面。
Int J Technol Assess Health Care. 2021 Apr 20;37(1):e57. doi: 10.1017/S026646232100026X.
2
New Health Technologies: A UK Perspective Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies".新型医疗技术：英国视角 评“为新型医疗技术创造价值：企业家、投资者和监管机构的早期贡献”。
Int J Health Policy Manag. 2017 Dec 1;6(12):721-722. doi: 10.15171/ijhpm.2017.59.
3
Creating win-win-win situations with managed entry agreements? Prioritizing gene and cell therapies within the window of opportunity.通过管理准入协议创造共赢局面？在机会之窗内优先考虑基因和细胞疗法。
Drug Discov Today. 2024 Jul;29(7):104048. doi: 10.1016/j.drudis.2024.104048. Epub 2024 Jun 1.
4
A different animal but the same beast? Using development-focused health technology assessment to define the value proposition of medical technologies.不同的动物却是同一类野兽？利用以发展为重点的卫生技术评估来界定医疗技术的价值主张。
Int J Technol Assess Health Care. 2021 Apr 19;37(1):e58. doi: 10.1017/S0266462321000209.
5
Health technology assessment of new retinal treatments; the need to capture healthcare capacity issues.新型视网膜治疗的卫生技术评估；把握医疗保健能力问题的必要性。
Eye (Lond). 2022 Dec;36(12):2236-2238. doi: 10.1038/s41433-022-02149-5. Epub 2022 Jun 28.
6
Creating value-focused healthcare delivery systems: Part three--Core competencies.创建以价值为导向的医疗服务体系：第三部分——核心竞争力。
J Oncol Manag. 1997 Nov-Dec;6(6):16-23.
7
Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies.为新医疗技术创造价值：企业家、投资者和监管机构的早期贡献。
Int J Health Policy Manag. 2017 Sep 1;6(9):509-518. doi: 10.15171/ijhpm.2017.11.
8
Healthcare technology, economics, and policy: an evolving balance.医疗保健技术、经济学与政策：一种不断演变的平衡。
IEEE Eng Med Biol Mag. 2003 Jan-Feb;22(1):16-9. doi: 10.1109/memb.2003.1191444.
9
Machine Learning Healthcare Applications (ML-HCAs) Are No Stand-Alone Systems but Part of an Ecosystem - A Broader Ethical and Health Technology Assessment Approach is Needed.机器学习医疗保健应用（ML-HCAs）并非独立系统，而是生态系统的一部分——需要一种更广泛的伦理和健康技术评估方法。
Am J Bioeth. 2020 Nov;20(11):46-48. doi: 10.1080/15265161.2020.1820104.
10
Health technology assessments, evidence-based healthcare and health ethics.卫生技术评估、循证医疗与卫生伦理。
Sao Paulo Med J. 2008 Sep;126(5):251. doi: 10.1590/s1516-31802008000500001.

引用本文的文献

1
Defining early health technology assessment: building consensus using Delphi technique.界定早期卫生技术评估：运用德尔菲法达成共识
Int J Technol Assess Health Care. 2025 Jun 2;41(1):e34. doi: 10.1017/S0266462325100123.
2
Identifying characteristics for a cost-effective psoriatic arthritis biomarker test: a development-focused health technology assessment.确定具有成本效益的银屑病关节炎生物标志物检测的特征：一项以开发为重点的卫生技术评估
Int J Technol Assess Health Care. 2025 May 23;41(1):e29. doi: 10.1017/S0266462325000091.
3
Assessing the Value of Further Investment in R&D Using Mixed Methods: A Case Study of Biosensor-Integrated Arteriovenous Grafts.
运用混合方法评估研发进一步投资的价值：以生物传感器集成动静脉移植物为例
J Mark Access Health Policy. 2025 Jan 15;13(1):1. doi: 10.3390/jmahp13010001. eCollection 2025 Mar.